Skip to content

Q2 Solutions (United Kingdom)

Request correction

Q2 Solutions, now IQVIA Laboratories, is a United Kingdom-based clinical laboratory services brand operating as part of IQVIA.

Last updated September 16, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Q2 Solutions is now IQVIA Laboratories, a global leader in drug discovery and development laboratory services offering central laboratory and specialty biomarker services. The brand is associated with a company in Livingston, United Kingdom, and operates under the IQVIA Laboratories identity.

History

Q2 Solutions is now IQVIA Laboratories. The brand is associated with a company in Livingston, United Kingdom. IQVIA Laboratories describes itself as a global leader in drug discovery and development laboratory services, offering central laboratory and specialty biomarker services, and works closely with customers to provide scientific and operational expertise, specialty lab services, and next-generation lab technologies.

Products and positioning

A global leader in drug discovery and development laboratory services, offering a comprehensive suite of central laboratory and specialty biomarker services.

  • Central Laboratory Services

    Central laboratory services for clinical trials.

  • Biomarker Services

    Specialty biomarker services.

  • Discovery Sciences

    Discovery sciences services.

  • Bioanalytical Laboratories

    Bioanalytical laboratory services.

  • Clinical Genomics Laboratory

    Clinical genomics laboratory services.

  • Vaccine Laboratory Services

    Vaccine laboratory services.

  • Digital Technologies

    Digital technologies for laboratory services.

Recent events

  • Reported

    Q2 Solutions and MindX Sciences announce partnership[4]

    Q2 Solutions and MindX Sciences announced a partnership under which Q2 Solutions will conduct genomics laboratory testing services for MindX Sciences blood tests.

  • Unconfirmed

    Reported

    IQVIA acquires Quest Diagnostics’ Q2 Solutions stake[5]

    IQVIA acquired Quest Diagnostics’ 40 percent minority share of Q2 Solutions for $760 million, resulting in IQVIA owning 100 percent. Quest Diagnostics was to remain Q2 Solutions clients’ strategic preferred laboratory provider under a multi-year agreement.

Read more

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/q2-solutions-united-kingdom · Editorial policy · How profiles are compiled